198 related articles for article (PubMed ID: 23840623)
1. Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
Sayeed A; Luciani-Torres G; Meng Z; Bennington JL; Moore DH; Dairkee SH
PLoS One; 2013; 8(6):e67191. PubMed ID: 23840623
[TBL] [Abstract][Full Text] [Related]
2. Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.
Busch S; Sims AH; Stål O; Fernö M; Landberg G
Cancer Res; 2015 Apr; 75(7):1457-69. PubMed ID: 25833830
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
[TBL] [Abstract][Full Text] [Related]
4. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
5. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
[TBL] [Abstract][Full Text] [Related]
6. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
AlHossiny M; Luo L; Frazier WR; Steiner N; Gusev Y; Kallakury B; Glasgow E; Creswell K; Madhavan S; Kumar R; Upadhyay G
Cancer Res; 2016 Jun; 76(11):3376-86. PubMed ID: 27197181
[TBL] [Abstract][Full Text] [Related]
7. Risk association of BST2 gene variants with disease progression in HIV-1 infected Indian cohort.
Gupte DS; Patil A; Selvaa Kumar C; Pandey S; Achrekar SK; Paranjape RS; Jagtap DD
Infect Genet Evol; 2020 Jun; 80():104139. PubMed ID: 31841700
[TBL] [Abstract][Full Text] [Related]
8. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
9. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
Yokoyama T; Enomoto T; Serada S; Morimoto A; Matsuzaki S; Ueda Y; Yoshino K; Fujita M; Kyo S; Iwahori K; Fujimoto M; Kimura T; Naka T
Int J Cancer; 2013 Jan; 132(2):472-84. PubMed ID: 22729361
[TBL] [Abstract][Full Text] [Related]
10. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
Pham QT; Oue N; Yamamoto Y; Shigematsu Y; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Tiwari M; Yasui W
Anticancer Res; 2017 Jun; 37(6):2853-2860. PubMed ID: 28551621
[TBL] [Abstract][Full Text] [Related]
11. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
Lee JY; Won HY; Park JH; Kim HY; Choi HJ; Shin DH; Kang JH; Woo JK; Oh SH; Son T; Choi JW; Kim S; Kim HY; Yi K; Jang KS; Oh YH; Kong G
J Clin Invest; 2015 May; 125(5):1801-14. PubMed ID: 25822021
[TBL] [Abstract][Full Text] [Related]
12. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
Joffroy CM; Buck MB; Stope MB; Popp SL; Pfizenmaier K; Knabbe C
Cancer Res; 2010 Feb; 70(4):1314-22. PubMed ID: 20145137
[TBL] [Abstract][Full Text] [Related]
14. BST2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus nucleocapsid protein with selective autophagy.
Kong N; Shan T; Wang H; Jiao Y; Zuo Y; Li L; Tong W; Yu L; Jiang Y; Zhou Y; Li G; Gao F; Yu H; Zheng H; Tong G
Autophagy; 2020 Oct; 16(10):1737-1752. PubMed ID: 31868081
[TBL] [Abstract][Full Text] [Related]
15. Promotion of BST2 expression by the transcription factor IRF6 affects the progression of endometriosis.
Li J; He Y; Qu Y; Ren C; Wang X; Cheng Y; Sun L; Zhang X; Zhang G
Front Immunol; 2023; 14():1115504. PubMed ID: 37143676
[TBL] [Abstract][Full Text] [Related]
16. BST2 promotes cell proliferation, migration and induces NF-κB activation in gastric cancer.
Liu W; Cao Y; Guan Y; Zheng C
Biotechnol Lett; 2018 Jul; 40(7):1015-1027. PubMed ID: 29774441
[TBL] [Abstract][Full Text] [Related]
17. BST2/Tetherin enhances entry of human cytomegalovirus.
Viswanathan K; Smith MS; Malouli D; Mansouri M; Nelson JA; Früh K
PLoS Pathog; 2011 Nov; 7(11):e1002332. PubMed ID: 22072961
[TBL] [Abstract][Full Text] [Related]
18. BST2 Promotes Tumor Growth via Multiple Pathways in Hepatocellular Carcinoma.
Xu X; Wang Y; Xue F; Guan E; Tian F; Xu J; Zhang H
Cancer Invest; 2020 May; 38(5):329-337. PubMed ID: 32427495
[TBL] [Abstract][Full Text] [Related]
19. Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling.
Bego MG; Mercier J; Cohen EA
J Virol; 2012 Apr; 86(7):3513-27. PubMed ID: 22301143
[TBL] [Abstract][Full Text] [Related]
20. The expression of BST2 in human and experimental mouse brain tumors.
Wainwright DA; Balyasnikova IV; Han Y; Lesniak MS
Exp Mol Pathol; 2011 Aug; 91(1):440-6. PubMed ID: 21565182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
